ID

14459

Beschreibung

Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab; ODM derived from: https://clinicaltrials.gov/show/NCT00199004

Link

https://clinicaltrials.gov/show/NCT00199004

Stichworte

  1. 16.04.16 16.04.16 -
Hochgeladen am

16. April 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Adult Acute Lymphocytic Leukemia NCT00199004

Eligibility Adult Acute Lymphocytic Leukemia NCT00199004

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
b-precursor all (common / pre b-all)
Beschreibung

Precursor B-cell lymphoblastic leukemia

Datentyp

boolean

Alias
UMLS CUI [1]
C1292769
standard risk
Beschreibung

standard risk

Datentyp

boolean

Alias
UMLS CUI [1]
C3641091
cd20 expression >20%
Beschreibung

cd20 expression

Datentyp

boolean

Alias
UMLS CUI [1]
C3278899
ph/bcr-abl negative
Beschreibung

ph/bcr-abl negative

Datentyp

boolean

Alias
UMLS CUI [1]
C2347493
age 15-65 years (55-65 if biologically younger)
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
written informed consent
Beschreibung

written informed consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
severe complications due to leukemia or secondary illnesses
Beschreibung

severe complications

Datentyp

boolean

Alias
UMLS CUI [1]
C0009566
late relapse of childhood all
Beschreibung

acute lymphocytic leukemia in relapse

Datentyp

boolean

Alias
UMLS CUI [1]
C2367454
cytostatic pretreatment
Beschreibung

Cytostatic chemotherapy

Datentyp

boolean

Alias
UMLS CUI [1]
C2609342
pregnancy
Beschreibung

pregnancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
severe psychiatric illness or other circumstances which may compromise cooperation of the patient or informed consent
Beschreibung

psychiatric illness

Datentyp

boolean

Alias
UMLS CUI [1]
C0004936
known severe allergy to foreign proteins
Beschreibung

known severe allergy to foreign proteins

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C2230096

Ähnliche Modelle

Eligibility Adult Acute Lymphocytic Leukemia NCT00199004

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Precursor B-cell lymphoblastic leukemia
Item
b-precursor all (common / pre b-all)
boolean
C1292769 (UMLS CUI [1])
standard risk
Item
standard risk
boolean
C3641091 (UMLS CUI [1])
cd20 expression
Item
cd20 expression >20%
boolean
C3278899 (UMLS CUI [1])
ph/bcr-abl negative
Item
ph/bcr-abl negative
boolean
C2347493 (UMLS CUI [1])
Age
Item
age 15-65 years (55-65 if biologically younger)
boolean
C0001779 (UMLS CUI [1])
written informed consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
severe complications
Item
severe complications due to leukemia or secondary illnesses
boolean
C0009566 (UMLS CUI [1])
acute lymphocytic leukemia in relapse
Item
late relapse of childhood all
boolean
C2367454 (UMLS CUI [1])
Cytostatic chemotherapy
Item
cytostatic pretreatment
boolean
C2609342 (UMLS CUI [1])
pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
psychiatric illness
Item
severe psychiatric illness or other circumstances which may compromise cooperation of the patient or informed consent
boolean
C0004936 (UMLS CUI [1])
known severe allergy to foreign proteins
Item
known severe allergy to foreign proteins
boolean
C0020517 (UMLS CUI [1,1])
C2230096 (UMLS CUI [1,2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video